ADGRD1 and central nervous system cancer: Necrotic and pseudopalisading zones within GBM promote the expression of GPR133 (ADGRD1), a member of the adhesion G protein–coupled receptor (AGPCR) family, specifically in CD133+ glioma stem cells.